Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Data, Analytics & AI · Conducting an NMA

Approaches to Conducting Network Meta-Analysis: Bayesian and Frequentist Methods, Software and Applications

The same network meta-analysis can be conducted with either a Bayesian or a frequentist method. A direct empirical comparison across simulated and real datasets found that the two approaches generally yield similar point estimates but differ in their handling of small networks and uncertainty.

Pubrica AcademyWritten by a biostatistics methodologist Reviewed byan evidence synthesis statistician Published10 October 2026 Last checked10 October 2026 Reading time8 minutes Sources10 peer-reviewed

Once a research team has determined that network meta-analysis is the appropriate tool, it must still select a statistical framework (Bayesian or frequentist) and a software platform, and these two choices offer different opportunities for what the analysis can report. Neither choice is dictated by the method itself: the same dataset and the same network of trials can be analyzed validly through either route, which is why it is worth the planning time to understand what each approach is suited for, rather than defaulting to whichever one the team already knows. A Bayesian framework, usually implemented through Markov chain Monte Carlo sampling in software such as WinBUGS, JAGS or Stan, produces full posterior distributions for every parameter, including treatment rankings, as a direct by-product of fitting the model. A frequentist framework, implemented in packages such as R’s netmeta, uses established meta-analytic machinery that is often faster to run and easier to audit, since it does not depend on convergence diagnostics for a sampling chain. Neither framework is inherently more rigorous than the other; both are built on the same underlying contrast-based statistical model formalized by Lu and Ades, and the choice between them is primarily a matter of practical fit, computational resources and reporting needs rather than of the scientific validity of the resulting estimates.

Learning objectives

  • The practical differences between Bayesian and frequentist approaches to network meta-analysis
  • The findings of an empirical head-to-head comparison of the two approaches
  • Which software platforms are commonly used for each approach, and the opportunities each provides

Common misconceptions

  • “The choice between Bayesian and frequentist methods is principally a matter of statistical preference with no practical consequence for the results.” A 2020 empirical comparison by Seide, Jensen, and Kieser found that, although Bayesian and frequentist random-effects network meta-analysis methods generally produced similar point estimates for binary outcomes, they could diverge meaningfully in networks with few studies per comparison, in which the choice of approach and of prior or method specification measurably affected the width and behavior of the resulting confidence or credible intervals.

Direct comparison of Bayesian and frequentist approaches

A Bayesian network meta-analysis specifies prior distributions for the model's parameters and updates them using the observed trial data through Markov chain Monte Carlo sampling, producing a posterior distribution for every treatment effect and, directly from that, a probability distribution over treatment rankings1. A frequentist network meta-analysis instead extends standard meta-analytic estimation, typically using a graph-theoretical or electrical-network analogy implemented in the R package netmeta, to produce point estimates and confidence intervals without requiring prior specification or sampling convergence diagnostics2. Seide, Jensen, and Kieser's 2020 empirical comparison in Research Synthesis Methods tested both approaches across a range of simulated and real network structures for binary outcomes and found that point estimates generally agreed well between the two frameworks, but that interval width and the behavior of random-effects variance estimation diverged more noticeably as the number of studies per comparison in the network grew smaller3. This finding has practical importance because sparse comparisons, those supported by only one or two trials, are common in real-world networks rather than rare, which means that the choice of framework is least consequential for the well-populated parts of a network and most consequential for precisely the comparisons in which an unexamined discrepancy between methods is least acceptable to decision-makers. The technical support documentation prepared by Dias and colleagues for the NICE Decision Support Unit sets out the generalized linear modeling framework underlying both approaches in more formal mathematical detail, and it is the standard reference against which UK health technology assessment submissions are prepared10.

Software for each approach

The 2017 tutorial by Shim and colleagues in Epidemiology and Health describes the practical software options available for each framework: Bayesian network meta-analysis is typically run through WinBUGS, OpenBUGS, JAGS or Stan, usually called from R, and requires authors to specify and justify prior distributions and to check Markov chain convergence before relying on the output4. These convergence checks, typically involving trace plots and statistics such as the Gelman-Rubin diagnostic, are not a minor technical detail: a model that has not converged can produce results that appear plausible but are not valid draws from the posterior distribution the analysis is intended to estimate, which is why reporting guidance for Bayesian network meta-analyses expects these diagnostics to be checked and, ideally, reported alongside the main results. Frequentist network meta-analysis is most commonly conducted with the netmeta package in R, which Rücker and Schwarzer extended with a method for ranking treatments without resampling, making frequentist ranking output directly comparable to Bayesian ranking probabilities without simulation5. Before this development, obtaining a ranking probability from a frequentist model required either bootstrapping or a switch to a Bayesian implementation for that output, so the method of Rücker and Schwarzer closed a genuine capability gap between the two frameworks rather than offering a stylistic alternative: teams working entirely within a frequentist framework gained access to ranking output that previously required leaving that framework, and this has in practice shifted a meaningful share of applied network meta-analyses toward frequentist tools. For teams preferring a graphical interface to writing code, the MetaInsight Shiny application, distributed through CRAN, wraps netmeta and gemtc functionality into a point-and-click tool for conducting and visualizing a network meta-analysis6. The choice of platform also affects how reproducible and auditable the final analysis is: R-based tools such as netmeta and gemtc produce a scripted, version-controllable record of every modeling decision, whereas a point-and-click tool trades some of that granular reproducibility for substantially lower setup time, a consideration most relevant to teams without dedicated biostatistical support for every project. Whichever platform is selected, authors should retain and archive the underlying analysis code or project file, not only the output tables, since a result that cannot be independently re-run from a saved script is harder to defend if a journal or health technology assessment body later requests a re-analysis or sensitivity check. This practice requires little effort during the project and is of considerable value if the analysis is questioned months or years after publication.

Joint ranking of all interventions in a network

Regardless of framework, the central opportunity that network meta-analysis offers, and that a standard pairwise meta-analysis cannot, is a single, internally consistent ranking across every intervention in the evidence base, rather than a series of separate pairwise verdicts that may not be mutually compatible7. Chaimani and colleagues describe graphical tools, including network geometry plots, forest plots organized by rank, and comparison-adjusted funnel plots for assessing small-study effects across a network, that become possible only once every intervention has been placed in a single connected model8. This is also the structural reason network meta-analysis has become central to health technology assessment and clinical guideline development, where decision-makers need to compare every available treatment option against every other, not just against a single reference standard9. This opportunity creates a corresponding communication challenge: presenting a full ranking across, for example, eight or ten treatments requires a different reporting approach from a simple forest plot designed for two groups, which is why rank-ordered displays, ranking probability tables and network geometry diagrams have become standard companions to the numerical results in a well-reported network meta-analysis rather than optional additions.

Selection of an approach for a given network

In practice, the choice between frameworks is often determined less by theoretical preference than by the structure of the network and the resources of the team. The NICE Decision Support Unit technical support documents of Dias and colleagues, which codified the generalized linear modeling approach underlying both frameworks for UK health technology assessment submissions, note that multi-arm trials in particular benefit from the correlated-effects handling that arises naturally within the Bayesian hierarchical modeling tradition; this is one concrete reason health technology assessment agencies have historically favored Bayesian implementations for formal decision-making submissions, even as frequentist tools have closed much of the practical gap10. A Bayesian approach is typically favored when the network includes multi-arm trials requiring correlated-effects modeling or when the project needs to formally incorporate external evidence through informative priors, while a frequentist approach is often favored for its speed, transparency, and lower computational overhead on simpler two-arm-dominated networks42. Whichever framework is chosen, the finding of Seide and colleagues that the two approaches can diverge more in sparse networks provides a direct, practical reason to report results from both where feasible, particularly for comparisons supported by only one or two small trials3. A practical compromise adopted by many well-resourced evidence synthesis teams is to conduct the primary analysis in the framework that best suits the overall structure of the network, and then to cross-check in the other framework any comparison identified as decision-critical (one that would materially change a treatment recommendation or reimbursement decision), rather than analyzing every comparison twice as a blanket policy. Teams should also document this choice, and the reasoning behind it, in the methods section, since a reviewer or appraiser evaluating the analysis against a checklist such as PRISMA-NMA or the ISPOR good-practice recommendations will look for a stated justification rather than inferring one from the software citation in the references.

Key points

Key points

Bayesian and frequentist network meta-analyses usually agree on point estimates but may diverge in sparse networks, and the principal opportunity offered by either approach is a single, internally consistent ranking of every intervention in the evidence base.

Practical application

Practical application

  1. The analytical framework should be selected according to the structure of the network rather than convention. A Bayesian approach is preferable for networks with multi-arm trials or where informative priors are required; a frequentist approach is preferable for speed and transparency in simpler networks.
  2. Results from both frameworks should be reported when a comparison rests on sparse evidence. Where only one or two small trials support a comparison, cross-checking Bayesian and frequentist estimates is a direct safeguard, given the documented divergence in sparse networks.
  3. Network geometry and ranking plots should be presented in addition to a summary table. Network diagrams, rank-ordered forest plots and comparison-adjusted funnel plots should be generated to communicate what a joint ranking shows, rather than reporting point estimates alone.

Frequently asked questions

No. Seide and colleagues' empirical comparison found the two approaches generally produced similar point estimates for binary outcomes, with the more notable differences appearing in networks sparse in studies per comparison.

No single platform is universally preferred; netmeta is widely used for frequentist analyses for its speed and transparency, while WinBUGS, JAGS, and Stan are standard for Bayesian analyses, and MetaInsight offers a no-code option wrapping both.

A single, internally consistent ranking across every intervention in the network at once, which supports decisions, such as health technology assessments or clinical guideline recommendations, that require comparing every available option rather than one pair at a time.

Yes, relative to frequentist methods. Bayesian network meta-analysis requires specifying and justifying prior distributions and checking Markov chain Monte Carlo convergence, both of which require statistical expertise beyond fitting the model itself.

Yes. The method of Rücker and Schwarzer allows frequentist network meta-analysis to generate ranking probabilities analogous to Bayesian SUCRA scores without resampling simulation.

References

  1. Shim S, Yoon BH, Shin IS, Bae JM. Network meta-analysis: application and practice using Stata. Epidemiology and Health. 2017;39:e2017047. read 10 October 2026. View on Epidemiology and Health
  2. Rücker G. Network meta-analysis, electrical networks and graph theory. Research Synthesis Methods. 2012;3(4):312-324. read 10 October 2026. View on Research Synthesis Methods
  3. Seide SE, Jensen K, Kieser M. A comparison of Bayesian and frequentist methods in random-effects network meta-analysis of binary data. Research Synthesis Methods. 2020;11(3):363-378. read 10 October 2026. View on Research Synthesis Methods
  4. Shim S, Yoon BH, Shin IS, Bae JM. Network meta-analysis: application and practice using R software. Epidemiology and Health. 2019;41:e2019013. read 10 October 2026. View on Epidemiology and Health
  5. Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Medical Research Methodology. 2015;15:58. read 10 October 2026. View on BMC Medical Research Methodology
  6. The MetaInsight Development Team. metainsight: A 'shiny' Application for Network Meta-Analysis. CRAN. read 10 October 2026. View on CRAN
  7. Mills EJ, Thorlund K, Ioannidis JPA. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914. read 10 October 2026. View on The BMJ
  8. Chaimani A, Higgins JPT, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLOS ONE. 2013;8(10):e76654. read 10 October 2026. View on PLOS ONE
  9. Jansen JP, Fleurence R, Devine B, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value in Health. 2011;14(4):417-428. read 10 October 2026. View on Value in Health
  10. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Medical Decision Making. 2013;33(5):607-617. read 10 October 2026. View on Medical Decision Making

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). Approaches to Conducting Network Meta-Analysis: Bayesian and Frequentist Methods, Software and Applications. Pubrica. https://pubrica.com/academy/concepts-definitions/what-are-the-commonly-used-approaches-opportunities-for-conducting-nma/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

NMA Framework Selection Worksheet

This checklist should be worked through before a Bayesian or frequentist approach is adopted for the network.

[ ] Counted multi-arm trials in the network and assessed whether correlated-effects modeling is needed
[ ] Checked whether any comparison rests on only one or two small trials (a sparse-network risk flag)
[ ] Decided whether informative priors are needed or appropriate for this evidence base
[ ] Selected software (netmeta, gemtc, WinBUGS/JAGS/Stan, or MetaInsight) matched to the chosen framework and team's expertise
[ ] Planned to cross-check Bayesian and frequentist estimates for any sparse comparisons

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s biostatistics team conducts network meta-analyses in both Bayesian and frequentist frameworks where sparse evidence warrants a cross-check, and matches the choice of software to the structure of the network and the reporting requirements of the client.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Pubrica can identify the network meta-analysis approach appropriate to a given evidence base.

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.